Marisa Co. serves as the Vice President of Real World Data Analytics, Innovation & Partnerships at Bristol Myers Squibb, where she plays a pivotal role in harnessing the power of advanced analytics and Real World Data (RWD) to enhance patient outcomes and drive business success....
Marisa Co. serves as the Vice President of Real World Data Analytics, Innovation & Partnerships at Bristol Myers Squibb, where she plays a pivotal role in harnessing the power of advanced analytics and Real World Data (RWD) to enhance patient outcomes and drive business success. With a robust background in biopharma, Marisa leads a global, multi-national team dedicated to developing innovative analytics solutions that support brand and asset reimbursement strategies. Her expertise in profit and loss (P&L) management and transformative leadership enables her to navigate complex market dynamics effectively, ensuring that Bristol Myers Squibb remains at the forefront of drug development and commercialization.
Currently, Marisa is spearheading the strategy and implementation of a new site in India, which is set to enhance the capabilities of the Business Insights & Analytics function. This initiative not only aims to streamline operations but also to leverage local talent in generating insights that can accelerate drug development timelines and optimize sales performance. Her commitment to cultivating high-performing, cross-functional teams has fostered a culture of collaboration and innovation, empowering her team to tackle challenges head-on and deliver measurable results.
Marisa’s strategic vision and analytical acumen are complemented by her ability to forge meaningful partnerships across the healthcare ecosystem. By aligning Bristol Myers Squibb’s objectives with the needs of patients and healthcare providers, she is driving initiatives that not only improve access to therapies but also enhance the overall patient experience. As a dynamic leader in the biopharma space, Marisa Co. continues to make significant strides in advancing the industry's understanding of Real World Evidence (RWE) and its critical role in shaping the future of healthcare.
